In general, the present invention is directed to a method of cooking wood in a cooking liquor medium. The method comprises a step of providing wood to a treatment vessel and contacting the wood with a digester additive composition. The composition comprises a first surfactant comprising an anionic surfactant, a derivative thereof, a salt thereof, or any combination thereof and a second surfactant comprising a polyoxyalkylene glycol or a derivative thereof. Additionally, according to another embodiment, the present invention is directed to a digester additive composition comprising a first surfactant comprising an anionic surfactant, a derivative thereof, a salt thereof, or any combination thereof and a second surfactant comprising a polyoxyalkylene glycol or a derivative thereof.

Described herein are methods and devices that allow the generation of [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides (such as [F-18]tosyl fluoride) in a manner that is suitable for radiosynthesis of F-18 labeled radiopharmaceuticals using currently available synthesis modules.

Described herein are methods and devices that allow the generation of [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides (such as [F-18]tosyl fluoride) in a manner that is suitable for radiosynthesis of F-18 labeled radiopharmaceuticals using currently available synthesis modules.

In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The medicant moiety can be a toxin including an acylfulvene or a drug moiety. The affinity moiety can be an antibody, a binding protein, a steroid, a lipid, a growth factor, a protein, a peptide or non peptidic. The affinity moiety can be covalently bound to the medicant via a linker. Novel linkers that can be directed to cysteine, arginine or lysine residues based on solution pH allow greater flexibility in preserving and/or generating specific epitopes in the AMC.

Aspects of the present disclosure include antibacterial aromatic sulfonyl fluoride agents. The subject aromatic sulfonyl fluoride agents have a pharmacophore that can provide for potent antibacterial activity. The subject agents are compounds including an aromatic group substituted with a sulfonyl fluoride warhead group and an electron withdrawing group. The subject agents find use in a variety of antibiotic applications. In some cases, the subject agents find use in methods of treating bacterial infections in a subject. Also provided are pharmaceutical compositions and kits that find use in practicing the subject methods.

In general, the present invention is directed to a method of cooking wood in a cooking liquor medium. The method comprises a step of providing wood to a treatment vessel and contacting the wood with a digester additive composition. The composition comprises a first surfactant comprising an anionic surfactant, a derivative thereof, a salt thereof, or any combination thereof and a second surfactant comprising a polyoxyalkylene glycol or a derivative thereof. Additionally, according to another embodiment, the present invention is directed to a digester additive composition comprising a first surfactant comprising an anionic surfactant, a derivative thereof, a salt thereof, or any combination thereof and a second surfactant comprising a polyoxyalkylene glycol or a derivative thereof.

In general, the present invention is directed to a method of cooking wood in a cooking liquor medium. The method comprises a step of providing wood to a treatment vessel and contacting the wood with a digester additive composition. The composition comprises a first surfactant comprising an anionic surfactant, a derivative thereof, a salt thereof, or any combination thereof and a second surfactant comprising a polyoxyalkylene glycol or a derivative thereof. Additionally, according to another embodiment, the present invention is directed to a digester additive composition comprising a first surfactant comprising an anionic surfactant, a derivative thereof, a salt thereof, or any combination thereof and a second surfactant comprising a polyoxyalkylene glycol or a derivative thereof.

In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The medicant moiety can be a toxin including an acylfulvene or a drug moiety. The affinity moiety can be an antibody, a binding protein, a steroid, a lipid, a growth factor, a protein, a peptide or non peptidic. The affinity moiety can be covalently bound to the medicant via a linker. Novel linkers that can be directed to cysteine, arginine or lysine residues based on solution pH allow greater flexibility in preserving and/or generating specific epitopes in the AMC.

In one aspect, there is provided a method of coupling an aromatic or vinylic compound having a fluorosulfonate substituent to a boron-containing compound. In another aspect, there is provided a method of coupling an aromatic or vinylic compound having a hydroxyl substituent to a boron-containing compound in a one-pot reaction.

In an embodiment of the invention, a composition for treating a cell population comprises an Affinity Medicant Conjugate (AMC). The medicant moiety can be a toxin including an acylfulvene or a drug moiety. The affinity moiety can be an antibody, a binding protein, a steroid, a lipid, a growth factor, a protein, a peptide or non peptidic. The affinity moiety can be covalently bound to the medicant via a linker. Novel linkers that can be directed to cysteine, arginine or lysine residues based on solution pH allow greater flexibility in preserving and/or generating specific epitopes in the AMC.